Trials / Sponsors / Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology Holdings, Inc.
Industry · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) Myelodysplastic Syndromes | Phase 1 / Phase 2 | 2019-04-01 |
| Completed | Phase I Study of LB-100 With Docetaxel in Solid Tumors Tumors, Neoplasms, Cancer | Phase 1 | 2013-02-01 |